Oramed Pharmaceuticals (ORMP) Divestments (2011 - 2025)

Oramed Pharmaceuticals (ORMP) reported Divestments of $2.8 million for Q3 2025, up 297.88% quarter-over-quarter from $706000.0 in Q2 2025.

Oramed Pharmaceuticals (ORMP) Divestments (2011 - 2025) Analysis & Trends

Oramed Pharmaceuticals has reported Divestments for 3 years, with the latest figure at $2.8 million in Q3 2025.

For the quarter ending Q3 2025, Divestments changed N/A year-over-year to $2.8 million; the trailing twelve-month figure through Dec 2025 stood at $6.3 million (changed N/A YoY), and the FY2025 full-year result was $6.3 million, changed N/A from the prior year.
Divestments for Q3 2025 stood at $2.8 million, up from $706000.0 in the prior quarter.
The five-year high for Divestments was $2.8 million in Q3 2025, with the low at $706000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-	-
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-	-
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-	-
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn	-
9	Abivax	91.71 Bn	91.71 Bn	-	-
10	Oramed Pharmaceuticals	151.47 Mn	133.31 Mn	-	-

Download Data